The multi-disciplinary panel will take samples ... Stella L vessel at the Deepwater Port on November 27, and found PDS rice onboard. After that a thorough verification process has been launched ...

PRINCETON, N.J., April 23, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy ...

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast ...

PDS Biotechnology is a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers. The Company has initiated a pivotal clinical trial to advance its ...

PDS Biotechnology PDSB will release its quarterly earnings report on Thursday, 2025-03-27. Here's a brief overview for investors ahead of the announcement. Analysts anticipate PDS Biotechnology to ...

HENDERSON, Nev., April 16, 2025 /PRNewswire/ -- PDS Health ™, a leading integrated healthcare support organization, has launched PDS Health Technologies ™, expanding its ability to deliver ...